未登录 分享 收藏
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC 携带EGFR突变型晚期非小细胞肺癌患者使用amivantamab-lazertinib的总体生存率 Yang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul 分享 收藏
分享 收藏
分享 收藏
Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC IMscin002研究的主要结果：一项评估患者对阿替利珠单抗皮下注射与静脉注射治疗NSCLC的偏好及对医疗专业人员的看法的研究。 Cappuzzo, Federico; Zvirbule, Zanete; Korbenfeld, Ernesto; Kolb-Sielecki, Jaroslaw; Isla, Dolores; Szczesna, Aleksandra; Sanchez, Amparo Yovanna Castro; Bustillos, Alberto; Young, Fiona; Tosti, Nadia; Monteiro, Marta Freitas; Majem, Margarita 分享 收藏
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Amivantamab联合Lazertinib治疗先前未经治疗的EGFR突变的晚期NSCLC Cho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi 分享 收藏
Immune-mediated secondary adrenal insufficiency is more commonly found in younger patients undergoing neoadjuvant treatment for early breast cancer 免疫介导的继发性肾上腺功能不全在年轻早期乳腺癌接受新辅助治疗的患者的发生率更高。 Lapuchesky, L. S.; Waisberg, F. D.; Mando, P.; Urtasun, F.; Robledo Salas, I.; Colucci, G.; Ipina, M. A.; Borello, A.; Morinigo Kober, M. M.; Mazzotta, A.; Nunell, M. A.; Gill, M.; Gomez-Abuin, G.; Gallina Nanni, C. R.; Costanzo, M. V.; Nervo, A. A.; Korbenfeld, E. P.; Caceres, M. V.; Perazzo, F.; Nadal, J. C. 分享 收藏
LuciA-15-A real-world prospective study of PARP inhibitors for the treatment of Latin American patients with HER-2 negative metastatic breast cancer with mutation of BRCA1/2 genes or in the Homologous Recombination Repair genes Petracci, Fernando E.; Villarreal-Garza, Cynthia; Arganaraz, Facundo; Abuin, Gonzalo Gomez; Penaloza, Jose; Flores, Marcos A.; Piazzoni, Luciano; Riggi, Cecilia; Fabiano, Lucia; Gonzalez, Lucia; Cieplinski, Belen; Rivero, Sergio; Korbenfeld, Ernesto; Mando, Pablo 分享 收藏
Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial Amivantamab联合lazertinib与osimertinib作为EGFR突变的晚期非小细胞肺癌 (NSCLC) 患者的一线治疗: MARIPOSA，一项III期，全球，随机，对照试验的主要结果 Cho, B. C.; Felip, E.; Spira, A. I.; Girard, N.; Lee, J. S.; Lee, S. H.; Ostapenko, Y. V.; Danchaivijitr, P.; Liu, B.; Alip, A.; Korbenfeld, E. P.; Dias, J.; Sun, T.; Martinez, M.; Bauml, J. M.; Shreeve, M.; Sethi, S.; Knoblauch, R. E.; Hayashi, H.; Lu, S. 分享 收藏
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors Fizazi, Karim; Drake, Charles G.; Beer, Tomasz M.; Kwon, Eugene D.; Scher, Howard, I; Gerritsen, Winald R.; Bossi, Alberto; van den Eertwegh, Alfons J. M.; Krainer, Michael; Houede, Nadine; Santos, Ricardo; Mahammedi, Hakim; Ng, Siobhan; Danielli, Riccardo; Franke, Fabio A.; Sundar, Santhanam; Agarwal, Neeraj; Bergman, Andre M.; Ciuleanu, Tudor E.; Korbenfeld, Ernesto; Sengelov, Lisa; Hansen, Steinbjorn; McHenry, M. Brent; Chen, Allen; Logothetis, Christopher 分享 收藏
REAL-WORLD TREATMENT PATTERNS OF EVEROLIMUS plus EXEMESTANE IN PATIENTS WITH HORMONE-RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-NEGATIVE ADVANCED BREAST CANCER BY LINE OF THERAPY: A GLOBAL CHART REVIEW Costanzo, V; Zarba, J.; Michelotti, A.; Livi, L.; Villanueva, C.; Bordonaro, R.; Sherstnev, V; Kowalyszyn, R.; Marinsek, N.; Zhou, Z.; Macalalad, A. R.; Koo, V; Trieschman, E.; Xie, J.; Signorovitch, J.; Petracci, F.; Korbenfeld, E.; Ratto, B.; Higuchi, K.; Saghatchian, M. 分享 收藏
分享 收藏
PREDICT (Patient Characteristics in REnal Cell Carcinoma and Daily PractICe Treatment With Sorafenib) Non-interventional Study - Final Report Jaeger, D.; Ma, J.; Korbenfeld, E.; Zemanova, M.; Leonhartsberger, N.; Stauch, K.; Boeckenhoff, A.; Yu, J.; Mardiak, J.; Escudier, B. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏